Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-21-011520
Filing Date
2021-03-08
Accepted
2021-03-08 17:05:53
Documents
12
Period of Report
2021-01-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A synh-8ka_20210121.htm   iXBRL 8-K/A 34447
  Complete submission text file 0001564590-21-011520.txt   164737

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA synh-20210121.xsd EX-101.SCH 5792
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE synh-20210121_lab.xml EX-101.LAB 19421
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE synh-20210121_pre.xml EX-101.PRE 11627
5 EXTRACTED XBRL INSTANCE DOCUMENT synh-8ka_20210121_htm.xml XML 4110
Mailing Address 1030 SYNC STREET MORRISVILLE NC 27560
Business Address 1030 SYNC STREET MORRISVILLE NC 27560 919-876-9300
Syneos Health, Inc. (Filer) CIK: 0001610950 (see all company filings)

EIN.: 273403111 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36730 | Film No.: 21722807
SIC: 8731 Services-Commercial Physical & Biological Research